Cargando…

Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report

We have developed a therapeutic vaccine consisting of a mixture of lethally-irradiated allogeneic cutaneous melanoma cell lines with BCG and GM-CSF as adjuvants. The CSF-470 vaccine is currently being assayed in a Phase II–III trial against medium-dose IFN-α2b. All vaccinated patients immunized intr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aris, Mariana, Bravo, Alicia Inés, Barrio, María Marcela, Mordoh, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378302/ https://www.ncbi.nlm.nih.gov/pubmed/25870600 http://dx.doi.org/10.3389/fimmu.2015.00144

Ejemplares similares

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
por: Mordoh, Ana, et al.
Publicado: (2022)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
por: Podaza, Enrique, et al.
Publicado: (2020)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
por: Bravo, Alicia Inés, et al.
Publicado: (2023)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
por: Mordoh, Ana, et al.
Publicado: (2023)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
por: Aris, Mariana, et al.
Publicado: (2015)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Melanoma Vaccines and Modulation of the Immune System in the Clinical Setting: Building from New Realities
por: Madorsky-Rowdo, Florencia Paula, et al.
Publicado: (2012)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment
por: Mordoh, Jose, et al.
Publicado: (2013)

Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma
por: Zhou, Xuezhi, et al.
Publicado: (2022)

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
por: von Euw, Erika M, et al.
Publicado: (2008)

Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein
por: Tian, Xiangxiang, et al.
Publicado: (2022)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Neutralizing Antibody Response in Dogs and Cats Inoculated with Commercial Inactivated Rabies Vaccines
por: SHIRAISHI, Rikiya, et al.
Publicado: (2013)

In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
por: Castiello, Luciano, et al.
Publicado: (2019)

Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation
por: Ma, Jing, et al.
Publicado: (2022)

Multi-omics analysis of Siglec family genes in cutaneous melanoma
por: Li, Kezhu, et al.
Publicado: (2023)

Dendritic Cell-Based Vaccine Efficacy: Aiming for Hot Spots
por: Pizzurro, Gabriela Andrea, et al.
Publicado: (2015)

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
por: Roberti, María Paula, et al.
Publicado: (2012)

Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
por: Rosenbaum, Pierre, et al.
Publicado: (2021)

Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
por: Bian, Lijun, et al.
Publicado: (2022)

Amelanotic metastatic cutaneous melanoma
por: Mendes, Marcela Sena Teixeira, et al.
Publicado: (2013)

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018)

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
por: Shafat, Manar S., et al.
Publicado: (2020)

Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
por: Salem, Deepak, et al.
Publicado: (2021)

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012)

Cutaneous Leishmaniasis Vaccination: A Matter of Quality
por: De Luca, Paula Mello, et al.
Publicado: (2016)

A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
por: Xue, Ya-Nan, et al.
Publicado: (2020)

Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells
por: Arriaga, Juan Martín, et al.
Publicado: (2017)

Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
por: Keon, Soledad Mac, et al.
Publicado: (2019)

Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
por: Germanó, María José, et al.
Publicado: (2022)

Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma
por: Li, Mingjia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3aqe4guqmjt3rdpvf3qhe18o8m